CLINICAL_TRIALS
ClinicalTrials.gov record update
Cardiac and Metabolic Effects of Dapagliflozin in the Failing Fontan Circulation: A Phase II, Prospective, Double-Blind Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06762964
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:13.483150+00:00
- Published At
- 2025-10-02T00:00:00+00:00
- Record Updated At
- 2025-10-02
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Fontan Circulation", "Single Ventricle Heart Disease", "HFpEF - Heart Failure With Preserved Ejection Fraction"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-10-02"- protocolSection.identificationModule.nctId
"NCT06762964"- protocolSection.identificationModule.officialTitle
"Cardiac and Metabolic Effects of Dapagliflozin in the Failing Fontan Circulation: A Phase II, Prospective, Double-Blind Study"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.